Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of I-131-huA33 with Concurrent Capecitabine
Rebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell, Tina Cavicchiolo, Tim Saunder, Graeme J O'Keefe, Aurora Poon, Sze Ting Lee, Roger Murphy, Wendie Hopkins, Fiona E Scott, Andrew M Scott
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2014
Awarded by National Health and Medical Research Council of Australia
Awarded by NIH
The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was supported, in part, by National Health and Medical Research Council of Australia grants 280912 and 487922, NIH R21 CA108145-01A1, and the Ludwig Institute for Cancer Research and by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. This study was conducted with full compliance with current laws of Australia and with approval of the Human Research Ethics Committee of the Austin Hospital, Melbourne, Australia, and the Protocol Review Committee, Ludwig Institute for Cancer Research, New York, New York. No other potential conflict of interest relevant to this article was reported.